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Abstract
Environmental estrogenic compounds which bind to the estrogen receptor (ER) can block or alter
endogenous functions of estrogen in reproductive and developmental stages. A microarray
technology is a very valuable method for the prediction of hormone-responsive activities in various
gene expressions. Thus, we investigated the altered gene expression by estrogen and endocrine
disruptors (EDs) using microarray technology in the uterus of immature rats. In this study, the
expression levels of only 555 genes (7.42%) among the 7636 genes spotted on microarray chips
were enhanced by more than two-fold following treatment with estradiol (E2), suggesting that
direct or rapid response to E2 is widespread at the mRNA levels in these genes. In addition,
elevated expression levels of the genes (over 2-fold) were observed by diethylstilbestrol (DES;
9.01%), octyl-phenol (OP; 8.81%), nonyl-phenol (NP; 9.51%), bisphenol-A (BPA; 8.26%) or genistein
(9.97%) in the uterus of immature rats. The expression levels of representative genes, i.e., calbindin-
D9k (CaBP-9k; vitamin D-dependent calcium-binding protein), oxytocin, adipocyte complement
related protein (MW 30 kDa), lactate dehydrogenase A and calcium binding protein A6 (S100a6;
calcyclin), were confirmed in these tissues by real-time PCR. In addition, the mRNA levels of these
genes by real-time PCR were increased at follicular phase when E2 level was elevated during
estrous cycle of adult female rats. In conclusion, these results indicate distinct altered expression
of responsive genes following exposure to E2 and estrogenic compounds, and implicate distinct
effects of endogenous E2 and environmental endocrine disrupting chemicals in the uterus of
immature rats.
Background
Environmental chemicals that disrupt endocrine function
are suspected for their adverse effects on the reproductive
system in wild animals and humans and are being increas-
ingly assumed for their possible participation in inducing
estrogenic effects. Furthermore, they are proposed to pos-
sess hormone-like properties, i.e., mimicking natural hor-
mones, inhibiting the action of hormones, and inducing
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abnormal gene expressions. Environmental estrogenic
compounds that bind to the estrogen receptors (ERs) can
block or alter endogenous estrogen functions in reproduc-
tive and developmental stages via an ER-mediated
response [1]. Examples of suspected environmental estro-
genic chemicals (endocrine disruptors; EDs) include poly-
chlorinated hydroxybiphenyls, DDT and its derivatives,
certain insecticides and herbicides (kepone and methoxy-
chlor), plastic components (bisphenol A) and some com-
ponents of detergents and their biodegradation products
(alkylphenols etc.). Although the activity of most of these
environmental estrogens is low when compared to endog-
enous or synthetic estrogens (17β-estradiol; E2 or ethi-
nylestradiol), dietary or environmental exposure
scenarios that led to the detection of significant quantities
of these substances in human urine and tissue sample
have been described [2].
The profound effects of E2 on cell growth, differentiation,
and general homeostasis of reproductive and other sys-
tems are mediated mainly by the temporal and cell type-
specific expression of different genes, whose products are
the molecules controlling these molecular events [3,4]. In
rats, the concentration of E2 is consistently low through-
out neonatal development and starts to increase after day
28 of age [5]. The uterus and ovaries are two of the most
sensitive tissues to E2, and both tissues express two forms
of ER, ERα and ERβ. In particular, ERα is predominantly
expressed in uteri while ERβ is expressed in ovaries [6,7].
Diethylstilbestrol (DES) is a synthetic estrogen which can
induce various reproductive alterations in humans [8,9]
and mice [10-12]. Numerous reproductive changes in
wildlife populations can be caused by EDs which resem-
ble DES [2]. Alkylphenols (APs), such as octyl-phenol
(OP) and nonylphenol (NP), were reported to bind
directly to the ER in trout, stimulate citelogenin gene
expression in trout hepatocytes, be mitogenic in MCF-7
cells and stimulate transcription in mammalian cells via
ER [12]. In vitro studies revealed that OP and NP are the
most potent estrogenic alkylphenols, and the potency of
OP has been shown to be approximately 10-3~10-7 relative
to 17β-estradiol [12-15]. Furthermore, the binding affin-
ity of BPA indicated that it is approximately 10000-fold
less potent than E2 and 20000-fold less potent than DES
for both ERα and ERβ receptors [16]. In vivo estrogenic
activities (400–1000 mg/kg/day) in immature or ovariec-
tomized rats and mice have been recognized. Thus, the
concentrations of EDs such as OP, NP, and BPA, in the
present study are expected to have similar effects as those
of steroid hormones. In addition, APs are weakly estro-
genic in traditional uterotropic assays as evidenced by the
increase in uterus weight [17]. In vitro assays, E2 has been
demonstrated to induce maximal proliferation of MCF-7
cells at 1 nM concentration, and OP and NP have been
found to be considerably potent compounds as estrogenic
chemicals at 1 and 10 μM, respectively. Treatments with
OP and NP inhibited the binding affinity of E2 to ER in
MCF-7 cells by a competitive ER binding assay [18].
Bisphenol A (BPA) is a particularly important environ-
mental estrogen. Not only in it widespread in the environ-
ment, but it is commonly ingested by humans, being
released by polycarbonate plastics, the lining of food cans,
and dental sealants [19]. BPA only acts as an agonist of
estrogen via ERβ whereas it has dual actions as an agonist
and antagonist in some types of cells via ERα Thus, the
activity of BPA may depend on the ER subtype and the tis-
sue involved [20]. ERβ has a higher relative binding affin-
ity to genistein (Gen) in in vitro assays compare with ERα
[6]. Genistein is readily absorbed [21,22] and act as a
pharmacological estrogen both in vitro and in vivo via ERs
[23-25]. Although an actual impact of environmental
estrogens on reproductive health is not well defined thor-
oughly, these chemicals have the potential to disrupt the
reproductive system and confirm its estrogen-like activity
in vitro [6]. Therefore, the changes in the expression of
estrogen target genes are considered to be a useful index
for evaluating the estrogenic activity of synthetic com-
pounds. However, it is difficult to predict the full range of
effects of estrogenic compounds from changes in the
expression levels of only well-known estrogen target
genes.
Reproductive organs are highly susceptible to hormonal
exposure during organ development and sex differentia-
tion. In our previous studies, we showed that NP, OP and
BPA have estrogenic activity, resulting in uterotrophic
effects in the uterus of rats treated with these compounds
[26,27]. In addition, we demonstrated that the CaBP-9k
gene is not expressed in the uterus of immature rats,
which do not obtain estrogen from ovaries, and that it is
regulated through the binding of the ER/estrogen complex
to the estrogen response element (ERE) in rats [26,28].
CaBP-9k mRNA in the uterus is known to fluctuate during
estrous cycle of rats depending on serum estrogen level.
CaBP-9k mRNA at diestrus was not detectable, but
increased at proestrus and reached the highest level at
estrus and then decreased as metestrus [29]. The aim of
this study was to identify estrogen-responsive genes by E2
and endocrine disrupting chemicals in the uterus of rats
and to determine whether estrogen responsive genes are
differentially regulated following exposure to these estro-
genic compounds by microarray analysis and real-time
PCR. Finally, we evaluated the correlations between E2-
induced and EDs-induced gene profiles, and confirmed
the biomarker among altered gene expression for screen-
ing potential EDs.Reproductive Biology and Endocrinology 2006, 4:49 http://www.rbej.com/content/4/1/49
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Materials and methods
Animals and treatments
Immature Sprague-Dawley rats (2-weeks of age) with
dams were obtained from Orient Co, Ltd. (Gyeonggi-do,
Korea). All animals were housed in polycarbonate cages,
and used after acclimation to an environmentally control-
led room (temperature: 23 ± 2°C, relative humidity: 50 ±
10%, frequent ventilation and a 12 h day/night cycle). To
determine the effect of EDs, each group of five animals
(14-days old) was injected subcutaneously (sc, 0.1 ml per
rat) with E2 (40 μg/kg BW; Sigma-Aldrich Corp, St. Louis,
MO, USA), DES (500 μg/kg BW; Sigma-Aldrich Corp), OP
(600 mg/kg BW; Fluka Chemie, Buchs, Switzerland), NP
(600 mg/kg BW; Sigma-Aldrich Corp), BPA (600 mg/kg
BW; Sigma-Aldrich Corp), and genistein (40 mg/kg BW;
Sigma-Aldrich Corp) by a single dose daily for 3 days and
euthanized 24 h after final injection. All chemicals were
dissolved in corn oil (Sigma-Aldrich Corp) as a vehicle.
The rats were injected with E2 (n = 3) as a positive control
or corn oil (n = 3) as a negative control daily for 3 days.
The uteri were washed in cold sterile 0.9% NaCl solution
(0.9% normal saline) and used for microarray and RT-
PCR analyses. All rats were euthanized at 24 h after the
injection.
It is believed that exposure to DES or endocrine disruptors
might be detrimental to development and differentiation,
although the effects may not be apparent until adulthood.
In the present study, treatment with estrogenic com-
pounds induced a significant increase in the mRNA
expression of specific genes in the neonate rat uterus. To
confirm altered gene expression profile by E2 or EDs in
the uterus of immature rats, adult female rats were also
employed to examine the elevated endogenous E2 in the
induction of these genes at proestrus and estrus during
estrous cycle. Estrous cycle was determined by the obser-
vation of three types of the cells derived from the vaginal
smears: leukocytes, cornified cells and nucleated epithe-
lial cells. Four stages of the estrous cycle (proestrus, estrus,
metestrus and diestrus) were determined as following cri-
teria: proestrus was characterized by many epithelial cells
and few leukocytes; estrus by many cornified cells and no
leukocytes; metestrus by some cornified cells and many
leukocytes; and diestrus by few epithelial cells and many
leukocytes. All animals were smeared daily, and the rats
that had three regular cycles were selected. Forty female
rats were randomly assigned to four groups according to
the respective phase of estrous cycle (proestrus, estrus,
metestrus and diestrus, n = 10 each) and euthanized
immediately. The uteri were washed in cold sterile 0.9%
NaCl solution (0.9% normal saline) and used for RNA
extraction. All experimental procedures and animal use
were approved by the Ethics Committee of the Chungbuk
National University.
RNA isolation and cDNA microarray analysis
Total RNA was extracted with Trizol (Invitrogen, Carlsbad,
CA, USA) according to manufacturer's suggested proce-
dure, and purified using RNeasy total RNA isolation kit
(Qiagen, Valencia, CA, USA) according to the manufac-
turer's instructions. DNA was digested using an RNase-
free DNase set (Qiagen) during RNA purification. Total
RNA was quantified by spectrophotometer and its integ-
rity was assessed by running on a 0.8% agarose gel. To
make cDNAs from mRNAs for microarray analysis, the
same quantity of each RNA sample from the treated
groups (n = 5) or control groups (n = 3) was pooled. A
cDNA microarray consists of 7636 cDNA spot including
Incyte clones, housekeeping genes and Arabidopsis DNA
as controls. The experiments were performed on the rat
cDNA microarray prepared as previously described [30].
The PCR reactions were prepared according to the stand-
ard protocol and reaction mixtures were subjected to be
amplified at 35 cycles. The primer pair used for amplifica-
tion was overlap primer-1 (5'-AAT TAA CCC TCA CTA
AAG GG-3') and overlap primer-2 (5'-GTA ATA CGA CTC
ACT ATA GGG C-3'). The size and amount of the PCR
products were verified on 1% agarose gel. The PCR prod-
ucts were purified by ethanol precipitation, then resus-
pended in 15 μl of hybridization solution (GenoCheck,
Korea), and spotted onto CMT-GAPS α silane slide glass
(Corning, NY) with a pixsys 5500 arrayer (Cartesian Tech-
nologies, CA) using 16-Stealth Micro spotting pins. The
printed slides were processed according to CMT-GAPS α
slide protocol. Briefly, the spots were re-hydrated with 1 ×
SSC for 1 min and then DNA linked using a UV
crosslinker (Stratagene, CA). The slides were soaked in the
succinic anhydride/sodium borate solution for 15 min
with gentle agitation and then transferred to a 95°C water
bath for 2 min. The slides were quickly transferred to 95%
ethanol for 1 min and then dried using a centrifuge at
3000 rpm for 20 sec.
Hybridization with fluorescent DNA probe
Total RNA was extracted from the treated and untreated
tissues from immature or adult rats at the indicated time
points using the TRI-REAGENT (MRC, OH) according to
the manufacturer's instructions. Fluorescent labeled
cDNA probes were prepared from 50 §P of total RNA by
oligo (dT)18-primed polymerization using SuperScript α
reverse transcriptase (Invitrogen, NY) in a total reaction
volume of 30 μl. The reverse transcription mixture
included 400 U Superscript RNase H-reverse transcriptase
(Invitrogen), 0.5 mM dATP, dTTP and dGTP, 0.2 mM
dCTP and 0.1 mM Cy3 or Cy5 labeled dCTP (NEN Life
Science Product Inc.). After reverse transcription, the sam-
ple RNA was degraded by adding 5 μl of stop solution (0.5
M NaOH/50 m EDTA) and incubating at 65°C for 10
min. The labeled cDNA mixture was then concentrated
using the ethanol precipitation method. After determin-Reproductive Biology and Endocrinology 2006, 4:49 http://www.rbej.com/content/4/1/49
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ing the target cDNA quality, cDNA samples derived from
the pooled uteri of five individual neonate rats from each
treated group were selected and hybridized. The concen-
trated Cy3 and Cy5 labeled cDNAs were resuspended in
10 μl of hybridization solution (GenoCheck). After two
labeled cDNAs were mixed, the mixture was denaturized
95°C for 2 min and then incubated in 45°C water cham-
ber for 20 min. The cDNA mixture was then placed at
three spotted slide positions and covered by a cover slip to
assess the overall quality of each sample. The slides were
hybridized for 12 h at 62°C hybridization chamber. The
hybridized slides were washed in 2 × SSC, 0.1% SDS for 2
min, 1 × SSC for 3 min, and then 0.2 × SSC for 2 min at
room temperature. The slides were centrifuged at 3000
rpm for 20 sec to be dried.
Scanning and image analysis
Hybridized slides were scanned with the Axon Instru-
ments GenePix 4000B scanner and the scanned images
were analyzed with the software program GenePix Pro 5.1
(Axon, CA) and GeneSpring 7.1 (Sillicongenetics, CA). In
order to allow algorithm to eliminate all bad spots, no
data points were eliminated by visual inspection from the
initial GenePix image. For signal normalization, house-
keeping genes (β-actin) and positive control genes (A.
thaliana genes) were spotted onto each slide. The signals
of these spots were used for normalization. To filter out
the unreliable data, spots with signal-to-noise (signal –
background – background SD) below 100 were not
included in the data. Data were normalized by global,
lowess, print-tip and scaled normalization for data relia-
bility. Data were sorted of above 2-fold altered genes
using GeneSpring 7.1 (Sillicongenetics) and a hierarchical
clustering analysis was performed using Pearson correla-
tion. The statistical significance of differential expression
was assessed by computing a q-value for each gene. To
determine the q-value, we used a permutation procedure,
and for each permutation a two-sample t-statistic was
computed for each gene. The result was considered signif-
icant when the logarithmic gene expression ratio of three
independent hybridizations was more than twofold the
difference in the expression level. The accuracy of micro-
array analysis in this study was confirmed by real-time
PCR.
Confirmation of microarray analysis with real-time PCR
The standard curve was generated for a standard RNA
preparation by serial dilution (1, 1/10, 1/100, 1/1000, 0).
A real-time PCR reaction was carried out in a 25 μl final
volume containing 12.5 μl of 2× premix (TaKaRa Bio
Inc.), 0.3 μl of each of forward and reverse primers, 1 μl of
cDNA, and distilled water up to 10.9 μl. The oligonucle-
otide sequences of primers were employed to detect vari-
ous genes as shown Table 1. Polymerase chain reaction of
amplification using the Smart Cycle System (TaKaRa Bio
Inc.) began with an initial denaturation at 95°C for 30
sec. Each of the 35 amplification cycles consisted of dena-
turation at 95°C for 5 sec, annealing at 55°C for 15 sec,
and extension at 72°C for 15 sec. Relative expression lev-
els of each sample were calculated based on the cycle
threshold (Ct) and monitored for an amplification curve.
The PCR amplification curves were evaluated by fluores-
cence of the double-stranded DNA-specific dye, SYBR
Green, versus the amount of standardized PCR product.
All gene expressions were normalized to Cytochrome oxi-
dase subunits I mRNA (IA, Housekeeping gene) as con-
trols.
Data analysis
Data are presented as the mean ± SD. The data were ana-
lyzed by non-parametric procedure of the Kruskal Wallis
test, followed by Dunnett's test for two-pair comparisons.
The each value of Dunnett's test was converted to rank for
statistical analysis. All statistical analyses were performed
with SAS. P < 0.05 was considered statistically significant.
Results
Global analysis of estrogen-regulated genes compared 
with endocrine disruptors
Following individual treatment of immature rats with
EDs, total RNAs from the uteri were isolated and proc-
essed by microarray analysis as described. Based on the
number of genes expressed in control versus treated sam-
ples, the overall pattern of altered gene expression was
similar between the control (vehicle-treated) and estro-
genic compound-treated (E2, DES, OP, NP, BPA or genis-
tein) rats. Although the number of genes whose
expression is altered by any chemical tested is modest,
there is substantial change in the gene expression altered
or modified by exposure to each compound. The mean
Table 1: Oligonucleotide sequences with predicted sizes of respective PCR product
Accession No. Gene name Forward sequence Reverse sequence Size
NM_012521 vitamin D-dependent calcium binding protein 5'-aagagcatttttcaaaaata-3' 5'-gtctcagaatttgctttatt-3' 314
NM_012996 Oxcytocin 5'-gaccttcatcatcgtactgg-3' 5'-gagttgctcttcttgctgac-3' 275
NM_144744 Adipocyte complement related protein of 30 kDa 5'-gtgttcttggtcctaagggt-3' 5'-tgtacaccgtgatgtggtag-3' 287
NM_017025 Lactate dehydrogenase A 5'-aggtgacactgactcctgac-3' 5'-gtgggattgtcacactaacc-3' 285
AF140232 S100 calcium binding protein A6 (calcyclin) 5'-cttctcgtggctatcttcc-3' 5'-actggacttgactgggatag-3' 289Reproductive Biology and Endocrinology 2006, 4:49 http://www.rbej.com/content/4/1/49
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values of the intensities of each spot in this study were cal-
culated, and are plotted in Fig. 1. The data shown in Fig. 1
are typical of the three self vs. self comparisons, which
showed that a more than 2-fold change would be neces-
sary to overcome the intrinsic variability introduced by
the hybridization procedure. For this reason, the data was
further filtered to select for genes that showed an absolute
differential of at least two-fold or greater. Of the 7479
genes examined, the change in the mRNA expressions of
85 genes was listed in the Additional file 1. In addition,
treatment with E2 resulted in the induction of 555 genes
by more than two-fold. About 7.42% of all genes were up-
regulated by E2 (Fig. 2A), causing no significant difference
in the expression of the remaining 92.58% of the genes.
As shown in Fig. 2A, the expression level significantly
increased in the uterus when treated with DES (9.01%) or
OP (8.81%). Furthermore, Table 2 shows the common 21
genes induced by E2, DES, and OP in the uterus of imma-
ture rats. In addition, a single treatment of NP (9.51%),
BPA (8.26%) or genistein (9.97%) induced a significant
increase in gene expressions in this tissue (Fig. 2B), and
there are 30 common genes by these EDs (Table 3). These
results indicate that significant gene profile is altered in
the uteri by E2 and EDs.
In this study, we extended a large-scale of microarray anal-
ysis to six other estrogenic compounds, and identified cru-
cial estrogen-responsive genes, which were either
common in all or specific to each or some of the com-
pounds. The results with all six compounds are shown in
Fig. 2C using a hierarchical clustering algorithm of the
mean values of triplicate slides and a pseudo-color visual-
ization matrix. The gene profile in red color shows a
higher expression than the control, while the gene profile
A scattergram of gene expression analyzed by DNA microarray Figure 1
A scattergram of gene expression analyzed by DNA microarray. For each gene, the relative mRNA level in the control is given 
on the x axis and the expression level for the same transcript in the experimental sample (estrogenic compound exposed) is 
plotted on the y axis. Each graph displays two lines indicating 2-fold up-regulation or down-regulation in the expression level of 
each individual probe set comparing treated vs. control sample. The linear line (P < 0.05) was fitted to the microarray data.Reproductive Biology and Endocrinology 2006, 4:49 http://www.rbej.com/content/4/1/49
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in green color shows a lower expression (Fig. 2C). These
genes might be universal estrogen – responsive genes
among various tissues. These compounds exhibited a rea-
sonable hierarchical clustering; DES or OP resembled to
E2. However, NP-induced gene profile is similar to that of
BPA or genistein.
Confirmation of estrogen-regulated genes by real-time 
PCR
The primer sets used in the RT-PCR are listed in Table 1,
and the altered genes which showed a high increase in the
uterus are listed in Fig. 3. The expression patterns of sev-
eral genes up-regulated by estrogen were confirmed to ver-
ify the results of the microarray analysis using real-time
PCR analysis. The rats were injected with endocrine dis-
ruptors to determine their effect on the induction of calbi-
ndin D9k (CaBP-9k) mRNA in the immature uterus. The
expression level of CaBP-9k mRNA significantly increased
when treated with OP (12.2-fold vs. vehicle), NP (14.2-
fold) and BPA (1.6-fold) for 3 days (Fig. 3). In addition,
CaBP-9k mRNA was markedly induced by a single dose of
E2 (9.1-fold) or DES (21.4-fold) as seen in Fig. 3. The
Venn diagram showing the number of genes induced by E2 and EDs Figure 2
Venn diagram showing the number of genes induced by E2 and EDs. The altered gene profiles by E2, OP and DES (overlapped 
21 genes; A) or NP, BPA and Gen (overlapped 30 genes B), respectively, were summarized. A hierarchical clustering analysis 
(C) was performed following treatments with E2 and other EDs in the uterus of immature rats. Two-dimensional hierarchical 
clustering was applied to the expression data from 7.5 k genes, which showed significant changes in the balanced differential 
expression. Increased expression levels are shown in red and decreased expression levels are shown in green.Reproductive Biology and Endocrinology 2006, 4:49 http://www.rbej.com/content/4/1/49
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induction of uterine oxytocin by estrogenic compounds
was further assessed by real-time RT-PCR. An increase in
oxytocin was observed in the uterus of rats as expected
when treated with a single of OP (13.6-fold), NP (17.4-
fold) and BPA (1.5-fold) for 3 days Furthermore, treat-
ment with a single dose of E2 (9.9-fold) or DES (30.5-
fold) resulted in an increase of oxytocin in this tissue.
Increased expression level of adipocyte complement
related protein (30 KDa; Acrp30) was observed when
treated with OP (14.1-fold), NP (9.4-fold) and BPA (1.7-
fold). In addition, a single dose of E2 (4.1-fold) or DES
(19.1-fold) induced a marked increase in Acrp30 (Fig. 3).
The treatment with E2 (2.3-fold), DES (3.1-fold), OP (2.6-
fold), and NP (2.5-fold) altered the expression level of lac-
tate dehydrogenase A (Ldha). As shown in Fig. 3, the
expression level of calcium binding protein A6 (S100a6)
in this tissue significantly increased when treated with OP
(3.1-fold) and NP (4.2-fold). In addition, a single dose of
E2 (2.8-fold) and DES (5.8-fold) treatment induced a sig-
nificant increase in the expression of calcium binding pro-
tein A6 mRNA in the uterus of rats. These results indicate
that estrogenic compounds in parallel with E2 in the
uterus regulate the expression levels of various genes.
Expression of estrogen-regulated genes during estrous 
cycle
To investigate the regulation of various genes in the uterus
of rats during estrous cycle, the expression levels of CaBP-
9k, oxytocin, Acrp30, Ldha, and S100a6 mRNA were ana-
lyzed by real-time PCR. They were highly expressed in the
uterus in a follicular phase (proestrus and estrus) com-
pared to a luteal phase (metestrus and diestrus) as shown
in Fig. 4. The level of CaBP-9k mRNA at follicular phase
increased up to 70.5-fold compared to that at luteal phase
(Fig. 4). In parallel with CaBP-9k mRNA, the expression
levels of oxytocin (13.4-fold, vs. luteal phase), Acrp30
(3.1-fold,  vs. luteal phase), Ldha (3.3-fold, vs. luteal
phase), and S100a6 (2.7-fold, vs. luteal phase) mRNAs at
follicular phase were up-regulated in this tissue, indicat-
ing that they are dominantly expressed during follicular
phase and weakly detected at luteal phase in the uterus of
mature rats.
Discussion
The microarray technique is a very valuable method for
the prediction of hormone-responsive activity in various
gene expressions. Estrogen plays an important role in var-
ious molecular events, but the molecular mechanisms
that are regulated by estrogen in the uterus remain largely
unknown. Therefore, the identification of estrogen-
induced gene expression is essential to understanding
how estrogenic compounds regulate uterine physiology
and pathology at the cellular level. In the present study,
microarray analysis showed that only 7.42% (555 genes)
of all genes spotted on the microarray slide were up-regu-
lated by more than two-fold following estrogen treatment,
suggesting that direct or rapid responses to estrogen is
widespread at the mRNA level. Furthermore, treatments
with DES (9.01%), OP (8.81%), NP (9.51%) BPA
(8.26%) or genistein (9.97%) showed an induction of dis-
Table 2: Altered genes induced by E2, DES and OP in the uterus of immature rats
Accession No. Gene name Gene symbol E2 DES OP
AF154245 3.20 4.47 2.66
AF494463 Seizure related 6 homolog (mouse) Sez6 3.32 2.47 3.44
NM_012843 Epithelial membrane protein 1 Emp1 2.24 2.24 3.21
AW915015 Discs, large homolog 3 (Drosophila) Dlgh3 2.19 3.29 2.75
AF039584 Decay accelarating factor 1 Daf1 6.35 6.46 8.47
NM_031029 Gamma-aminobutyric acid (GABA) A receptor, pi Gabrp 2.59 2.90 4.10
NM_133296 X transporter protein 3 Xtrp3 2.25 2.11 4.12
AF020045 Integrin, alpha E, epithelial-associated Itgae 6.54 3.01 2.15
NM_031698 Ribophorin II Rpn2 3.45 2.09 3.16
NM_031977 Rous sarcoma oncogenes Src 2.28 2.29 2.13
NM_021702 Ataxin 3 Atxn3 2.61 5.68 2.79
AF151982 Secretory leukocyte peptidase inhibitor Slpi 2.11 2.89 2.26
NM_019188 Beta-microseminoprotein Msmb 2.29 3.14 3.42
NM_019369 Inter alpha-trypsin inhibitor, heavy chain 4 Itih4 2.43 2.47 3.12
U06752 Mucin 4 Muc4 3.99 5.84 4.10
NM_019278 Regulated endocrine-specific protein 18 Resp18 2.37 4.15 3.78
NM_017025 Lactate dehydrogenase A Ldha 2.17 2.06 2.10
NM_134377 Calsyntenin 2 Cstn2 2.60 2.46 2.42
AJ223184 Immunoglobulin superfamily, member 6 Igsf6 7.61 2.23 2.38
AI556074 Myristoylated alanine rich protein kinase C substrate Marcks 2.08 2.80 2.43
NM_145788 TRAF family member-associated Nf-kappa B activator Tank 3.00 3.05 2.82Reproductive Biology and Endocrinology 2006, 4:49 http://www.rbej.com/content/4/1/49
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tinct genes by more than two-fold in the uterus. Recently,
gene profile patterns by microarray technology were deter-
mined in the developing uterus and ovaries of Sprague-
Dawley rats at different stages of the development
exposed to graded dosages (sc) of 17alpha-ethynyl estra-
diol (EE), Gen, or BPA [31,32]. This analysis of the tran-
script profile in a dose-dependent manner revealed that a
common set of genes are altered, but some of the genes are
differentially changed by these estrogenic chemicals [31].
Interestingly, 592 genes of immature rat showed strong
and consistent changes in expression after EE exposure
[33], indicating that previously identified estrogen-sensi-
tive genes are sensitive to EE exposure and that they are
targets of the estrogenic action of EDs in both the uterus
and the ovary. In actual, the level of EDs in nature is low
compared with using dosage in the present study. For
example, several studies have been performed to assess
the presence of EDs in milk. EDs were determined in milk
and infant formula at concentrations from 0.4 to 81 μg/kg
in NP [34], or 0.1 to 13.2 μg/kg in BPA [35], respectively.
Although we are aware that we used the high dose of EDs,
this study focused to describe estrogen specific genes
using cDNA microarray to detect estrogenicity in vivo fol-
lowing treatment with EDs.
Uterine CaBP-9k may be involved in controlling myome-
trial activity which is affected by the intracellular calcium
level; however, the exact role of CaBP-9k in the uterus is
still under investigation by us and other research groups
[36]. Recently, it has been demonstrated in our previous
studies that both CaBP-9k mRNA and protein could be a
novel biomarker for estrogenic compounds in the uterus
of immature rats [26,27]. Based on the previous results,
the present study was performed to further investigate
EDs-induced specific gene expression in the uterus follow-
ing treatment with DES, E2 and estrogenic compounds
such as OP, NP, BPA and genistein. Thus, the expression
levels of CaBP-9k mRNA were analyzed to confirm the
estrogenic effect of these compounds in this tissue. E2 is a
major factor controlling CaBP-9k gene expression in the
rat uterus. The CaBP-9k gene is not expressed in the uterus
of mature ovariectomized and immature rats which do
not have circulating E2 from ovaries [37]. Using microar-
ray, the expression level of uterine CaBP-9k mRNA was
Table 3: Altered genes induced by NP, BPA, and Gen in the uterus of immature rats
Accession No. Gene name Gene symbol NP BPA Gen
NM_017224 Solute carrier family 22 (organic anion transporter), member 6 Slc22a6 2.95 2.09 2.12
NM_012500 N-acylaminoacyl-peptide hydrolase Apeh 3.93 2.53 2.08
U12571 Rabphilin 3A homolog (mouse) Rph3a 2.48 2.04 4.11
L34821 Aldehyde dehydrogenase family 5, subfamily A1 Aldh5a1 5.27 2.33 2.77
AF053317 Solute carrier family 21, member 1 Slc21a1 2.05 2.21 3.82
AF115282 Inhibitor of kappaB kinase beta Ikbkb 2.19 2.58 3.64
NM_024484 Aminolevulinic acid synthase 1 Alas1 15.07 3.65 5.16
NM_017208 Lipopolysaccharide binding protein Lbp 2.68 12.17 4.15
NM_133392 Serine/threonine kinase 17b (apoptosis-inducing) Stk17b 3.12 3.91 2.18
X55969 Apolipoprotein B Apob 2.31 2.41 2.35
NM_019333 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 Pfkfb4 2.48 2.81 2.51
NM_031698 Ribophorin II Rpn2 2.81 3.15 10.86
AJ293948 Kelch repeat and BTB (POZ) domain containing 10 Kbtbd10 2.50 2.43 2.71
D13127 ATP synthase, H+ transporting, O subunit Atp5o 2.55 3.02 2.40
NM_021689 Epiregulin Ereg 2.31 3.07 2.32
NM_022709 SMR2 Smr2 8.56 24.93 68.75
BF549833 Transcribed locus, strongly similar to XP_130951.1 dolichyl-phosphate 
mannosyltransferase polypeptide 3 [Mus musculus]
3.36 2.20 4.24
X59290 Eph and elk-related kinase LOC60589 2.16 2.75 4.81
BF521799 Transcribed locus, moderately similar to XP_525535.1 similar to Yippee-like protein 1 
(DiGeorge syndrome-related protein FKSG3)
5.14 2.72 3.61
NM_031577 Growth hormone releasing hormone Ghrh 3.72 5.51 2.39
NM_017145 Mast cell protease 1 Mcpt1 2.57 2.19 2.98
U57062 Granzyme C Gzmc 6.65 2.50 2.08
NM_130421 Lymphocyte cytosolic protein 2 Lcp2 2.72 2.50 2.14
NM_031971 Heat shock 70 kD protein 1A Hspa1a 3.62 2.25 2.29
M83680 RAB14, member RAS oncogene family Rab14 3.03 4.36 3.06
AJ132846 Sodium-dependent neutral amino acid transporter ASCT2 Slc1a5 2.77 2.19 2.73
NM_138532 Non-metastatic cells 7, protein expressed in Nme7 3.63 2.38 2.96
AF168795 CDK107 Slfn3 3.03 3.04 6.29
U22520 Chemokine (C-X-C motif) ligand 10 Cxcl10 2.05 2.19 3.87
NM_031785 ATPase, H+ transporting, lysosomal (vacuolar proton pump), subunit 1 Atp6ap1 3.81 3.52 3.93Reproductive Biology and Endocrinology 2006, 4:49 http://www.rbej.com/content/4/1/49
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significantly increased when treated with E2 (4.2-fold),
DES (7.32-fold), OP (3.09-fold), and NP (2.57-fold) in
the uterus of immature rats [see Additional file 1]. In preg-
nant rats, a relative potency of estrogenic compounds
indicated OP = NP > BPA [38]. Despite different potency
in estrogenicity, E2 and the estrogenic compounds tested
in this study induced a significant increase of CaBP-9k
mRNA in the uterus of immature rats. The expression pro-
file potentially provides a wealth of data about the differ-
ences in gene expression between experimental samples;
however, these differences do not always reflect realistic
mRNA levels. The induction of uterine CaBP-9k by estro-
genic compounds was further assessed by real-time RT-
PCR. Although the gene expression levels by microarray
analysis were not identical to those obtained PCR analy-
sis, the expression patterns of these genes obtained by
these two types of analysis were largely similar. In agree-
ment with a previous study [29], there was no change in
the expression pattern of CaBP-9k mRNA during the
estrous cycle. Estrogen stimulated the number of uterine
oxytocin binding sites, and oxytocin receptor mRNA
expression in ovariectomized virgin rats [39,40]. In rats,
during the terminal stages of pregnancy, the myometrium
is extremely sensitive to oxytocin and this increase in uter-
ine responsiveness occurs in parallel with increases in the
number of uterine oxytocin binding sites [39]. This leads
to increased uterine responsiveness to oxytocin and the
onset of the uterine contractions that facilitate parturition.
The change in uterine responsiveness to oxytocin involves
an increase in the quantity of oxytocin receptor protein
per cell and the number of smooth muscle cells that
express oxytocin receptors [41]. Based on the treatments
with EDs, increased expression levels of oxytocin mRNA
were observed when rats were treated with OP (14.76-
fold) and NP (9.54-fold), and a single dose treatment
with DES (5.70-fold) and E2 (5.83-fold) for 3 days. How-
ever, treatments with BPA and genistein for 3 days failed
to detect the expression level of oxytocin mRNA [see Addi-
tional file 1]. These observations raise the possibility that
the increase in the oxytocin mRNA level shown in Figure
3, occurs, at least in part, as a result of the injected estro-
genic compounds and that the PCR data and microarray
data are in general agreement. Furthermore, the present
study indicated at least that oxytocin mRNA which can be
amplified with the primer set increase about 2-fold on
proestrus compared with the value on metestrus. The
mRNA levels of oxytocin increased 2-fold between mete-
strus and proestrus by Northern blot analysis during
Confirmation of gene profiles by real-time PCR analysis Figure 3
Confirmation of gene profiles by real-time PCR analysis. Relative values of expression of the altered genes quantified by real-
time PCR are shown in graphs, indicating the comparison of fold change determined by real-time PCR analysis by E2, DES, OP, 
NP, BPA, and Gen in the uteri of immature rats. The representative genes are CaBP-9k, oxytocin, adipocyte complement 
related protein (MW 30 kDa), lactate dehydrogenase A and calcium binding protein A6 (calcyclin). Total RNAs from the uterus 
following treatment with estrogenic compounds were used to quantify altered gene expression normalized by cytochrome oxi-
dase subunits I (1A) as a control.Reproductive Biology and Endocrinology 2006, 4:49 http://www.rbej.com/content/4/1/49
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estrous cycle, while oxytocin binding increased more than
10-fold within this same interval in the uterus of rats [40].
In the present study, the expression level of adiponectin
(adipocyte complement-related protein of 30 kDa,
Acrp30) in the uterus of rats increased in microarray anal-
ysis following with E2 (5.86-fold), DES (6.26-fold), OP
(5.97-fold), and NP (10.05-fold) treatments. Using real-
time PCR analysis, we confirmed the expression of Acrp30
mRNA in the neonatal uteri following injection with EDs.
Although the rates of Acrp induction were not identical
from microarray analysis, treatment with E2, DES, OP and
NP resulted in significant increases in Acrp30 mRNA. Fur-
thermore, our results showed that Acrp30 fluctuated dur-
ing the estrous cycle, suggesting that steroid hormones
play a role in the regulation of Acrp30. Acrp30 is
expressed exclusively in the adipocytes, its hormone is
exclusively secreted by differentiated adipocytes [42], and
its protein was secreted and detected in plasma [43]. The
levels of the adipocyte hormones, leptin and adiponectin,
appear to be correlated with the cell proliferation index
and sex steroid receptor abundance [44]. Furthermore,
OVX in young cycling mice induced plasma Acrp30, and
E2 implants reversed the effect [45]. However, our results
indicate that E2, DES, OP and NP up-regulated its level,
suggesting that it does not imply any reverse effect in this
tissue.
The lactate dehydrogenase-A (Ldha) is hormonally regu-
lated in rodents and in highly expressed in the rat mam-
mary gland during pregnancy and lactation, and Ldha
mRNA also increases during mammary gland tumorigen-
esis [46]. E2 induces lactate dehydrogenase activity in
MCF-7 human breast cancer cells, and is elevated in estro-
gen receptor positive or progesterone receptor positive
tumors [47]. The synthesis of Ldha isoenzyme was found
to increase significantly in the uterus of immature mice,
and expression from the mouse lactate dehydrogenase-A
promoter fused to the cat gene in Chinese hamster ovary
cells was also induced by E2 and DES [48]. Using micro-
array, the expression level of uterine Ldha mRNA was sig-
nificantly increased when treated with E2 (2.17-fold),
DES (2.06-fold), OP (1.77-fold), and NP (2.72-fold) in
the uterus of immature rats [see Additional file 1]. In addi-
tion, we further investigated the expression of Ldha
mRNA related to estrogen during estrus cycle. A significant
increase in Ldha mRNA was detected at proestrus and
estrus compared with metestrus and diestrus. The expres-
sion pattern of Ldha mRNA during the estrous cycle was
in parallel with CaBP-9k mRNA, whereas others appeared
to peak at estrus compared to their level at proestrus.
Calcyclin (S100A6), a small acidic protein that weighs
about 10 kDa, belongs to the S100 calcium-binding pro-
tein family [49]. These family members share a common
S100 calcium-binding motif and are implicated in several
regulatory functions that include protein phosphoryla-
tion, some enzyme activities, the dynamics of cytoskeletal
components, transcription factors, and Ca2+ homeostasis,
and also cell proliferation and differentiation [50]. The
effect of E2 on the expression level of calcyclin mRNA in
uteri was further examined to elucidate a relationship
between expression levels of calcyclin and estrogenic com-
pounds. E2 resulted in an induction of uterine calcyclin
mRNA in immature rats. In addition, treatment with
estrogenic compounds resulted in a significant increase in
the expression of calcyclin mRNA, whose level paralleled
those of oxytocin and Acrp30, as shown in the Additional
file 1 and Fig. 3. After adjusting the data, it is clear that
major alterations in gene profiles were induced by estro-
genic compounds, such as E2, DES, OP, and NP, and that
these differences could have a significant effect on uterine
function in reproductive tissues during the estrous cycle.
Taken together, we demonstrated that an alteration in var-
ious mRNAs of gene profiles is one of the most significant
factors at the transcriptional level in the reproductive tis-
sue following E2, DES or estrogenic compounds. In addi-
tion, the expression patterns of CaBP-9k, oxytocin, Acrp,
Ldha, and calcyclin mRNAs were altered in the uterus of
immature rats during the estrous cycle. In conclusion,
these results indicate distinct altered expression of respon-
sive genes following exposure to estrogen and estrogenic
Expression of CaBP-9k, oxytocin, Acrp30, Ldha and calcyclin  mRNAs in the uterus of adult rats during estrous cycle Figure 4
Expression of CaBP-9k, oxytocin, Acrp30, Ldha and calcyclin 
mRNAs in the uterus of adult rats during estrous cycle. To 
investigate the expression of these genes during estrous 
cycle, the expression levels of these genes in the uterus of 
adult female rats were analyzed by real-time PCR. Data were 
analyzed by non-parametric procedure of the Kruskal Wallis 
test, followed by Dunnett's test for two-pair comparisons. 
The values represent means ± SD. a, P < 0.05 vs. Metestrus 
and Diestrus.Reproductive Biology and Endocrinology 2006, 4:49 http://www.rbej.com/content/4/1/49
Page 11 of 12
(page number not for citation purposes)
compounds, and implicate differential effects of estrogen
and environmental endocrine disrupting chemicals in the
uterus of immature rats.
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